Market Research Logo

Global Antidepressants Drugs, Devices And Therapies Market Forecast 2019-2027

Global Antidepressants Drugs, Devices And Therapies Market Forecast 2019-2027

KEY FINDINGS

The global anti-depressant drugs, devices and therapies market is anticipated to grow at a CAGR of 1.81% CAGR during the year 2019-2027. The revenue generated by the market is expected to increase from $15,569 million in 2018 and reach $18,183 million by 2027. The antidepressant drugs, devices, and therapies market is primarily driven because of factors such as a shift in the geriatric population size, growing awareness about depression as a medical disorder and the surge in sales of antidepressants in the past few years.

MARKET INSIGHTS

The market is segmented into types of antidepressants drugs, types of devices and the types of therapies for further simplification and a thorough study of the services and trends followed by the market players. The high cost for depression therapies, patent expiration faced by the companies for several drugs, coupled with the delay in product launches are majorly restraining the progression and expansion of the market. However, with the rising awareness about depression being a medical condition, the market is expected to show a huge promise during the forecasted years. Moreover, the rapid ongoing research and development activities for the drug discovery in the global depressant market are expected to find new, cost-effective and impactful antidepressant drug.

REGIONAL INSIGHTS

Geographically, the global anti-depressant drugs, devices, and therapies market is bifurcated into North America, Europe, Asia Pacific, and the remaining countries constituting the Rest of World segment.

The North American market is expected to hold the biggest share by 2027 on account of its developed healthcare system and increased expenditure on mental health treatment. However, this market is facing a possibility of dilution on account of the patent expiry of most of the prescribed drugs. On the contrary, the Asia-Pacific market is expected to be the fastest-growing region for the anti-depressant drugs, devices, and therapies market. The level of awareness regarding depression is steadily increasing in countries such as India, China, Japan, and South Korea, as deducted from the significant market share determined by our study, which determines this region as a prospective market in the upcoming years.

COMPETITIVE INSIGHTS

Branded drug manufacturing companies generally invest in R&D and produce drugs in-house. Some of the major blockbuster drugs produced by branded drug companies are H. Lundbeck AS, Boehringer Ingelheim GmbH, Allergan PLC, Mayo Clinic, Brainsway, Pfizer, Neuronetics, Abbot Laboratories, F. Hoffmann-La Roche Ltd., Eli Lilly, and Company and GlaxoSmithKline. They have reaped billions of dollars by having market exclusivity and patents.


1. Research Scope
1.1. Study Goals 1.2. Scope Of The Market Study 1.3. Who Will Find This Report Useful? 1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data 2.1.1. Secondary Data 2.1.2. Primary Data 2.2. Top-down Approach 2.3. Bottom-up Approach 2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary 3.2. Key Findings 3.2.1. Serotonin And Norepinephrine Reuptake Inhibitors (Snris) Is The Dominant Drug In Antidepressants Market3.2.2. Deep Brain Stimulator Is Expected To Grow Fast Among Other Devices Over The Forecast Period 3.2.3. Cognitive Behavior Therapy (Cbt) Is The Largest Contributor To Antidepressants Therapies Market
4. Market Dynamics
4.1. Market Definition & Scope 4.2. Market Drivers 4.2.1. Rise In The Number Of Depression Patients 4.2.2. Increase In Ageing Population 4.2.3. Rising Consciousness Of Depression As A Medical Disorder 4.2.4. Surge In Sales Of Antidepressants 4.3. Market Restraints 4.3.1. High Cost Of Depression Therapy 4.3.2. Patent Expiration Faced By The Companies 4.3.3. Delay In Product Launches 4.4. Market Opportunities 4.4.1. Huge Market Potential 4.4.2. More Preference For Personnel Therapy & Device Treatment 4.5. Market Challenges 4.5.1. Stiff Competition From The Generic Drugmakers
5. Market By Antidepressants Drugs
5.1. Serotonin And Norepinephrine Reuptake Inhibitors (Snris)5.2. Tricyclic Antidepressants (Tca) 5.3. Monoamine Oxidase Inhibitors (Maois) 5.4. Atypical Antidepressants 5.5. Selective Serotonin Reuptake Inhibitors 5.6. Benzodiazepines 5.7. Anticonvulsants 5.8. Beta-blockers 5.9. Other Antidepressants Drugs
6. Market By Devices
6.1. Deep Brain Stimulators 6.2. Fisher Wallace Stimulators 6.3. Transcranial Magnetic Stimulator 6.4. Other Devices
7. Market By Therapies
7.1. Cognitive Behavior Therapy (Cbt) 7.2. Electroconvulsive Therapy (Ect) 7.3. Rational Emotive Behavior Therapy (Rebt) 7.4. Other Therapies
8. Key Analytics
8.1. Porter’s Five Force Model 8.1.1. Threat Of New Entrants 8.1.2. Threat Of Substitute 8.1.3. Bargaining Power Of Suppliers 8.1.4. Bargaining Power Of Buyers 8.1.5. Threat Of Competitive Rivalry 8.2. Opportunity Matrix 8.3. Vendor Landscape 8.4. Value Chain Analysis 8.4.1. For Drugs 8.4.2. For Devices 8.5. Key Buying Criteria
9. Geographical Analysis
9.1. North America 9.1.1. United States 9.1.2. Canada 9.2. Europe 9.2.1. Germany 9.2.2. United Kingdom 9.2.3. France 9.2.4. Spain 9.2.5. Italy 9.2.6. Russia 9.2.7. Roe (Rest Of Europe) 9.3. Asia Pacific 9.3.1. India 9.3.2. China 9.3.3. Japan 9.3.4. South Korea 9.3.5. Australia 9.3.6. Rest Of Asia Pacific (Roapac) 9.4. Rest Of World 9.4.1. Latin America 9.4.2. Middle East And Africa
10. Competitive Landscape
10.1. Market Share Analysis10.2. Company Profile 10.2.1. Abbot Laboratories 10.2.2. Allergan Plc 10.2.3. Boehringer Ingelheim Gmbh 10.2.4. Brainsway 10.2.5. Eli Lilly And Company 10.2.6. F. Hoffmann-la Roche Ltd. 10.2.7. Glaxosmithkline 10.2.8. H. Lundbeck As 10.2.9. Mayo Clinic 10.2.10. Neuronetics 10.2.11. Pfizer
List Of Tables
Table 1 Global Antidepressants Drugs, Devices And Therapies Market, By Geography, 2019-2027, (In $ Million) Table 2 Landscape Of Drug Expiry And Launches In The United States Table 3 Global Antidepressants Drugs, Devices And Therapies Market, By Antidepressants Drugs, 2019-2027, (In $ Million) Table 4 Global Antidepressants Drugs Market, By Geography, 2019-2027, (In $ Million)Table 5 Global Serotonin And Norepinephrine Reuptake Inhibitors (Snris) Market, By Region, 2019-2027, (In $ Million) Table 6 Global Tricyclic Antidepressants (Tca) Market, By Region, 2019-2027, (In $ Million)Table 7 Global Monoamine Oxidase Inhibitors (Maois) Market, By Region, 2019-2027, (In $ Million) Table 8 Global Atypical Antidepressants Market, By Region, 2019-2027, (In $ Million) Table 9 Global Selective Serotonin Reuptake Inhibitors Market, By Region, 2019-2027, (In $ Million) Table 10 Global Benzodiazepines Market, By Region, 2019-2027, (In $ Million) Table 11 Global Anticonvulsants Market, By Region, 2019-2027, (In $ Million) Table 12 Global Beta-blockers Market, By Region, 2019-2027, (In $ Million) Table 13 Global Other Antidepressants Drugs Market, By Region, 2019-2027, (In $ Million) Table 14 Global Antidepressants Drugs, Devices And Therapies Market, By Devices, 2019-2027, (In $ Million) Table 15 Global Devices Market, By Geography, 2019-2027, (In $ Million) Table 16 Global Deep Brain Stimulators Market, By Region, 2019-2027, (In $ Million) Table 17 Global Fisher Wallace Stimulators Market, By Region, 2019-2027, (In $ Million)Table 18 Global Transcranial Magnetic Stimulator Market, By Region, 2019-2027, (In $ Million) Table 19 Global Other Devices Market, By Region, 2019-2027, (In $ Million) Table 20 Global Antidepressants Drugs, Devices And Therapies Market, By Therapies, 2019-2027, (In $ Million) Table 21 Global Therapies Market, By Geography, 2019-2027, (In $ Million) Table 22 Global Cognitive Behavior Therapy (Cbt) Market, By Region, 2019-2027, (In $ Million) Table 23 Global Electroconvulsive Therapy (Ect) Market, By Region, 2019-2027, (In $ Million) Table 24 Global Rational Emotive Behavior Therapy (Rebt) Market, By Region, 2019-2027, (In $ Million) Table 25 Global Other Therapies Market, By Region, 2019-2027, (In $ Million) Table 26 Opportunity Matrix Table 27 Vendor Landscape Table 28 Global Antidepressants Drugs, Devices And Therapies Market, By Geography, 2019-2027, (In $ Million) Table 29 North America Antidepressants Drugs, Devices And Therapies Market, By Country, 2019-2027 (In $ Million) Table 30 Europe Antidepressants Drugs, Devices And Therapies Market, By Country, 2019-2027 (In $ Million) Table 31 Asia Pacific Antidepressants Drugs, Devices And Therapies Market, By Country, 2019-2027 (In $ Million) Table 32 Rest Of World Antidepressants Drugs, Devices And Therapies Market, By Regions, 2019-2027 (In $ Million)
List Of Figures
Figure 1 Global Antidepressants Drugs, Devices And Therapies Market Share, By Drugs 2018 & 2027 (%) Figure 2 Snris Market, 2019 - 2027 (In $ Million) Figure 3 Deep Brain Stimulators Market, 2019 - 2027 (In $ Million) Figure 4 Cognitive Behavior Therapy (Cbt) Market ($ Million) Figure 5 Global Antidepressants Drugs, Devices And Therapies Market, By Cognitive Behavior Therapy (Cbt), 2019-2027, (In $ Million) Figure 6 Global Antidepressants Drugs, Devices And Therapies Market, By Electroconvulsive Therapy (Ect), 2019-2027, (In $ Million) Figure 7 Global Antidepressants Drugs, Devices And Therapies Market, By Rational Emotive Behavior Therapy (Rebt), 2019-2027, (In $ Million) Figure 8 Global Antidepressants Drugs, Devices And Therapies Market, Other Therapies, 2019-2027, (In $ Million) Figure 9 Porter’s Five Force Model Figure 10 Value Chain Of Antidepressant Drugs Figure 11 Value Chain Analysis For Device Market Figure 12 Global Antidepressants Drugs, Devices And Therapies Market, Regional Outlook, 2018 & 2027, (%) Figure 13 United States Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 14 Canada Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million Figure 15 Germany Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 16 United Kingdom Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 17 France Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 18 Spain Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 19 Italy Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 20 Russia Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 21 Roe Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 22 India Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 23 China Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 24 Japan Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 25 South Korea Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 26 Australia Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 27 Rest Of Asia Pacific Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 28 Latin America Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 29 Middle East And Africa Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 30 Market Share Of Antidepressants Drug Manufacturers (Percentage Of Sales), 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report